MicroRNA Array Market Still Experiencing 'Significant Growth,' Vendors, Users Say | GenomeWeb

By Justin Petrone

Microarrays for studying microRNAs first hit the market around four years ago, but the market for these products is still on the ascent, according to manufacturers and customers. Some microRNA array vendors say the market for their tools continues to grow, and users say that there continues to be compelling reasons to add miRNA-expression profiling to their research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.